IRADIMED CORPORATION

Informe acción NasdaqGM:IRMD

Capitalización de mercado: US$622.8m

Salud financiera de hoja de balance de IRADIMED

Salud financiera controles de criterios 6/6

IRADIMED tiene un patrimonio de accionistas total de $76.1M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $88.0M y $11.9M respectivamente. El BAIT de IRADIMED es de $20.8M, por lo que su ratio de cobertura de intereses es de -11.1. Tiene efectivo e inversiones a corto plazo que ascienden a $45.1M.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de intereses-11.5x
EfectivoUS$48.54m
PatrimonioUS$79.67m
Total pasivoUS$10.28m
Activos totalesUS$89.95m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

Aug 08
IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Feb 23
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Feb 07
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Nov 06
Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

Oct 13
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Feb 05
At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y

Oct 10

IRadimed: Record Revenue Could Translate To Share Price Appreciation

Aug 23

Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

Aug 17
Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

Jul 29

IRadimed: Reduce Equity Beta With Upside Capture

Jul 18

IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

Jul 13
IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Feb 05
At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Jan 12
Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture

Jul 13
Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($71.9M) de IRMD superan a sus pasivos a corto plazo ($7.6M).

Pasivo a largo plazo: Los activos a corto plazo de IRMD ($71.9M) superan a sus pasivos a largo plazo ($4.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: IRMD está libre de deudas.

Reducción de la deuda: IRMD no tenía deudas hace 5 años.

Cobertura de la deuda: IRMD no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: IRMD no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.


Hoja de balance


Descubre empresas con salud financiera